VTVT Annual Revenue
N/A
31 December 2023
Summary:
VTVT annual revenue is not available.VTVT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VTVT Quarterly Revenue
N/A
30 September 2024
Summary:
VTVT quarterly revenue is not available.VTVT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VTVT TTM Revenue
N/A
30 September 2024
Summary:
VTVT TTM revenue is not available.VTVT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VTVT Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
VTVT Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
VTv Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $1.00 M(>+9900.0%) | $1.00 M(-50.4%) |
| Dec 2022 | $2.02 M(-49.6%) | $9000.00(0.0%) | $2.02 M(-59.8%) |
| June 2022 | - | $9000.00(-99.6%) | $5.02 M(0.0%) |
| Mar 2022 | - | $2.00 M(>+9900.0%) | $5.02 M(+25.3%) |
| Dec 2021 | $4.00 M(-37.6%) | $9000.00(-99.7%) | $4.00 M(-61.5%) |
| Sept 2021 | - | $3.00 M(>+9900.0%) | $10.39 M(+40.4%) |
| June 2021 | - | $9000.00(-99.1%) | $7.40 M(+0.1%) |
| Mar 2021 | - | $987.00 K(-84.6%) | $7.39 M(+15.3%) |
| Dec 2020 | $6.41 M(+132.1%) | $6.40 M(>+9900.0%) | $6.41 M(>+9900.0%) |
| Sept 2020 | - | $7000.00(-12.5%) | $22.00 K(-98.8%) |
| Mar 2020 | - | $8000.00(+14.3%) | $1.85 M(-33.0%) |
| Dec 2019 | $2.76 M(-77.8%) | $7000.00(-12.5%) | $2.76 M(-62.0%) |
| Sept 2019 | - | $8000.00(-99.6%) | $7.28 M(-31.6%) |
| June 2019 | - | $1.83 M(+98.5%) | $10.65 M(-5.7%) |
| Mar 2019 | - | $921.00 K(-79.6%) | $11.29 M(-9.2%) |
| Dec 2018 | $12.43 M | $4.52 M(+34.0%) | $12.43 M(+52.7%) |
| Sept 2018 | - | $3.38 M(+36.5%) | $8.14 M(+70.2%) |
| June 2018 | - | $2.47 M(+19.8%) | $4.79 M(+105.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $2.06 M(+785.8%) | $2.33 M(+699.0%) |
| Dec 2017 | $291.00 K(-54.1%) | $233.00 K(+1453.3%) | $291.00 K(+203.1%) |
| Sept 2017 | - | $15.00 K(+15.4%) | $96.00 K(-19.3%) |
| June 2017 | - | $13.00 K(-56.7%) | $119.00 K(-58.7%) |
| Mar 2017 | - | $30.00 K(-21.1%) | $288.00 K(-54.6%) |
| Dec 2016 | $634.00 K(+22.2%) | $38.00 K(0.0%) | $634.00 K(-22.9%) |
| Sept 2016 | - | $38.00 K(-79.1%) | $822.00 K(-10.4%) |
| June 2016 | - | $182.00 K(-51.6%) | $917.00 K(+8.5%) |
| Mar 2016 | - | $376.00 K(+66.4%) | $845.00 K(+62.8%) |
| Dec 2015 | $519.00 K(-66.5%) | $226.00 K(+69.9%) | $519.00 K(-57.7%) |
| Sept 2015 | - | $133.00 K(+20.9%) | $1.23 M(-17.9%) |
| June 2015 | - | $110.00 K(+120.0%) | $1.49 M(-5.7%) |
| Mar 2015 | - | $50.00 K(-94.6%) | $1.58 M(+2.3%) |
| Dec 2014 | $1.55 M(+58.7%) | $934.00 K(+133.5%) | $1.55 M(+151.9%) |
| Sept 2014 | - | $400.00 K(+99.0%) | $615.00 K(+186.0%) |
| June 2014 | - | $201.00 K(+1335.7%) | $215.00 K(+1435.7%) |
| Mar 2014 | - | $14.00 K | $14.00 K |
| Dec 2013 | $976.00 K | - | - |
FAQ
- What is the all time high annual revenue for vTv Therapeutics?
- What is the all time high quarterly revenue for vTv Therapeutics?
- What is the all time high TTM revenue for vTv Therapeutics?
What is the all time high annual revenue for vTv Therapeutics?
vTv Therapeutics all-time high annual revenue is $12.43 M
What is the all time high quarterly revenue for vTv Therapeutics?
vTv Therapeutics all-time high quarterly revenue is $6.40 M
What is the all time high TTM revenue for vTv Therapeutics?
vTv Therapeutics all-time high TTM revenue is $12.43 M